Clinical Trial Update: Genetic Basis for Variation in the Renal Elimination of Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial examining genetic factors that impact the renal elimination of metformin; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Other Conditions That May Be A Focus of Clinical Attention | Phase 4 | Status: COMPLETED | Results posted: 2013-01-10